Exogene
PrivateLast Round
Grant
Oct 15, 2025
Total Funding Raised
$5.55M
Company Overview
Exogene is a biotechnology company that utilizes an artificial intelligence platform for the discovery and development of T-cell receptor (TCR)-based cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exogene Comparables
Compare Exogene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synteny | 93% | |
| Etcembly | 91% | |
| ImmunoScape | 77% | |
Exogene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Convertible Debt | Oct 10, 2025 | ||||
| Seed | Apr 28, 2022 |
Key People
Founding team and executive leadership
Exogene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Seed |
| Selvedge Venture | Seed |
| R42 Group | Seed |
| Entrepreneurs First | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2025
Added Immunocore Ltd, a mid-market biotechnology company, as a customer.
Exogene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exogene's valuation, stock price, and market status.